Tuberculosis vaccine candidate VPM1002 safe in HIV- and non-HIV-exposed newborns as study shows | Max-Planck-Gesellschaft https://www.mpg.de/19040549/0801-bich-tuberculosis-vaccine-candidate-vpm1002-safe-in-hiv-and-non-hiv-exposed-newborns-as-study-shows-17216463-x?c=152624
The vaccine candidate VPM1002 shows its safety in a study with HIV- and non-HIV-exposed newborns
Diseases, June 27, 2022 DOI Further information Website